Literature DB >> 8667411

Growth hormone modulates IL-alpha and IFN-gamma release by murine splenocytes activated by LPS or porins of Salmonella typhimurium.

L Sommese1, G Donnarumma, C de l'Ero, A Marcatili, M Vitiello, M Galdiero.   

Abstract

The effect of growth hormone (GH) on the release of IL-1alpha and IFN-gamma from murine splenocytes was investigated. Their release from splenocytes activated by Salmonella enterica serovar Typhimurium lipopolysaccharide (LPS) 0.5 microg/ml was increased by c. 65% in the presence of GH 100 pg/ml. With splenocytes activated by S. Typhimurium porins 5 microg/ml, GH increased the production of both IL-1alpha and IFN-gamma by c. 56%. Polymyxin treatment abolished the cytokine-releasing activity of LPS but had no effect on the activity of the porin preparation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667411     DOI: 10.1099/00222615-45-1-40

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides.

Authors:  K M Williams; E C Bigley; R B Raybourne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice.

Authors:  K Takagi; F Suzuki; R E Barrow; S E Wolf; D N Herndon
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

3.  Optimization of production of recombinant human growth hormone in Escherichia coli.

Authors:  Marzieh Rezaei; Sayyed H Zarkesh-Esfahani
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

4.  High level expression of recombinant human growth hormone in Escherichia coli: crucial role of translation initiation region.

Authors:  Mahsa Ghavim; Khalil Abnous; Fatemeh Arasteh; Sahar Taghavi; Maryam Sadat Nabavinia; Mona Alibolandi; Mohammad Ramezani
Journal:  Res Pharm Sci       Date:  2017-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.